HCPCS Level II · Outpatient PPS (temporary codes)
C9290Injection, bupivacaine liposome, 1 mg
Terminated 12/31/2024
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9290
C9290 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing injection, bupivacaine liposome, 1 mg.
It was added to HCPCS effective 04/01/2012, and its current record took effect 01/01/2025.
It was terminated on 12/31/2024 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Inj, bupivacaine liposome
- Date added
- 04/01/2012
- Action effective
- 01/01/2025
- Termination date
- 12/31/2024
- BETOS
- O1E
Related C92xx codes
Common questions about C9290
Is HCPCS C9290 still valid?
- No. C9290 was terminated on 12/31/2024.
Does Medicare cover C9290?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.